EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Immune checkpoint inhibitor-induced myocarditis: focus on the downstream pathogenic components and potential therapeutics

Yifan Chen, Xuejun Wang, Yihui Shen, Hui Zhang, Cheng Yu, Leilei Cheng, Junbo Ge

Seminars in Cancer Biology · 2026

DOI: 10.1016/j.semcancer.2025.12.004 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Seminars in Cancer Biology, 2026. Verfasst von Yifan Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, National Clinical Research Center for …. Hauptthemen laut MEDLINE: Myocarditis, Immune Checkpoint Inhibitors, Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 101 Literaturangaben. Gefördert von: Chinese Academy of Medical Sciences, National Natural Science Foundation of China, Shanghai Shenkang Hospital Development Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Advent of immune checkpoint inhibitors (ICIs) has renovated onco-immunotherapy, with around 50 % of cancer patients suitable for the treatment. However, patients treated by ICIs are in jeopardy for immune-related adverse events (irAEs) that attack any organ including the heart. ICIs-induced myocarditis (ICIIM) is an uncommon but possibly fatal irAE. With the increasing use of ICIs and improved diagnosis of this disease, the incidence of ICIIM is growing rapidly. In this review, we briefly overview roles of T cells and their immune checkpoints, and categorize the pathogenic process of ICIIM into three stages (upstream, midstream and downstream), with addressing recent research progress on the pathogenic mechanisms in each stage, particularly focusing on the downstream core pathogenic components and potential therapeutics for this disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MyocarditisImmune Checkpoint InhibitorsNeoplasmsHumansAnimalsImmunotherapy

Stichwörter der Autor:innen

Immune checkpoint inhibitorsMacrophagesMitophagyMyocarditisNLRP3 inflammasomeT cells

Substanzen

Immune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, National Clinical Research Center for Interventional Medicine, Shanghai 200032, China; Department of Cardiol…
  • Shanghai Institute of Cardiovascular Diseases, National Clinical Research Center for Interventional Medicine, Department of Echocardiography, Zhongshan Hospital, Fudan University, Shanghai Institute of Medical Imaging,…
  • Department of Cardiology, Fujian Medical University Union Hospital, Fujian Provincial Center for Cardiovascular Medicine, Fujian Institute of Coronary Artery Disease, Fuzhou 350001, China.
  • Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, National Clinical Research Center for Interventional Medicine, Shanghai 200032, China. Electronic address: j…

Förderung

  • Chinese Academy of Medical Sciences
  • National Natural Science Foundation of China
  • Shanghai Shenkang Hospital Development Center

Zitieren

APA

Chen, Y., Wang, X., Shen, Y., Zhang, H., Yu, C., Cheng, L., & Ge, J. (2026). Immune checkpoint inhibitor-induced myocarditis: focus on the downstream pathogenic components and potential therapeutics. Seminars in Cancer Biology. https://doi.org/10.1016/j.semcancer.2025.12.004

Vancouver

Chen Y, Wang X, Shen Y, Zhang H, Yu C, Cheng L, et al. Immune checkpoint inhibitor-induced myocarditis: focus on the downstream pathogenic components and potential therapeutics. Seminars in Cancer Biology. 2026. doi:10.1016/j.semcancer.2025.12.004

BibTeX
@article{Chen2026,
  author = {Chen, Yifan and Wang, Xuejun and Shen, Yihui and Zhang, Hui and Yu, Cheng and Cheng, Leilei and Ge, Junbo},
  title = {Immune checkpoint inhibitor-induced myocarditis: focus on the downstream pathogenic components and potential therapeutics},
  journal = {Seminars in Cancer Biology},
  year = {2026},
  doi = {10.1016/j.semcancer.2025.12.004}
}
Kostenlos starten →